CCN Proteins and Breast Cancer

$160,564U54FY2011CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

Paper 39064812 Paper 37536390 Paper 37289038 Paper 36334805 Paper 36291938 Paper 35908246 Paper 35486908 Paper 34251581 Paper 33644256 Paper 33414544 Paper 33344150 Paper 33311440 Paper 33230738 Paper 32964365 Paper 32462055 Paper 32451329 Paper 32368438 Paper 32006900 Paper 31663018 Paper 31538568 Paper 31236478 Paper 31226312 Paper 31101096 Paper 31057308 Paper 30934991 Paper 30914750 Paper 30791936 Paper 30771431 Paper 30736768 Paper 30680648 Paper 30478421 Paper 30464589 Paper 30388069 Paper 30338035 Paper 30250641 Paper 29932172 Paper 29930868 Paper 29808718 Paper 29745264 Paper 29594759 Paper 29503311 Paper 29146555 Paper 29099049 Paper 29064397 Paper 28948137 Paper 28560447 Paper 28474005 Paper 28348459 Paper 28337662 Paper 28179289 Paper 28115363 Paper 27959387 Paper 27846392 Paper 27282431 Paper 27279256 Paper 27151407 Paper 27035792 Paper 26892043 Paper 26862150 Paper 26821054 Paper 26403635 Paper 26138082 Paper 26131760 Paper 26032819 Paper 25986880 Paper 25975952 Paper 25874233 Paper 25751766 Paper 25727979 Paper 25421674 Paper 25147334 Paper 24772452 Paper 24510435 Paper 24297065 Paper 24065096 Paper 23787099 Paper 23775785 Paper 23708256 Paper 23165325 Paper 23071104 Paper 23045270 Paper 22942183 Paper 22940912 Paper 22937117 Paper 22922257 Paper 22580610 Paper 21765475 Paper 21732345 Paper 21517135 Paper 21455569 Paper 20162579

Abstract

Relevance: There is a critical need to understand the pathogenesis of breast cancer, in particular in minority and underserved populations who have poor survival. The purpose of this project is to develop a comprehensive breast cancer research project that provides the opportunity to identify novel biological targets for diagnosis and to follow progression of cancer in response to therapy in Minority and Underserved populations.

View original record on NIH RePORTER →